Concepedia

Publication | Open Access

Effect of pemafibrate on liver enzymes and shear wave velocity in non-alcoholic fatty liver disease patients

DOIFull Paper Access

20

Citations

30

References

2023

Year

Ryosuke Sugimoto, Motoh Iwasa, Akiko Eguchi, Yasuyuki Tamai, Ryuta Shigefuku, Naoto Fujiwara, Hideaki Tanaka, Yoshinao Kobayashi, Jiro Ikoma, Masahiko Kaito,
Frontiers in Medicine

Abstract

Pemafibrate significantly improves liver function, serum TG and liver stiffness in NAFLD patients. Pemafibrate is a promising therapeutic agent for NAFLD and may be a candidate for NAFLD patients with elevated TG.

References

YearCitations

Page 1